Back to BlackRock, Inc. BlackRock, Inc.

REGNREGN
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in REGENERON PHARMACEUTICALS

BlackRock, Inc. holds 9.1M shares of REGN (REGENERON PHARMACEUTICALS), worth $5.7B as of 2026-Q2. The position was increased (+1.9% shares). REGN represents 0.1% of BlackRock, Inc.'s portfolio.

Current Value

$5.7B

Current Shares

9.1M

Total Value Change

-$537.2M

Total Shares Change

+381,884

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
9.1M
+1.9%
$5.7B0.1%$623.54
32
2026-Q1
Increased
8.9M
+2.4%
$6.9B0.1%$766.66
39
2025-Q4
Decreased
8.7M
-1.1%
$6.7B0.1%$773.94
0
2025-Q3
Decreased
8.8M
-4.7%
$5B0.1%$560.05
0
2025-Q2
Increased
9.3M
+3.9%
$4.9B0.1%$519.56
33
2025-Q1
Increased
8.9M
+2.2%
$5.7B0.1%$634.66
39
2024-Q4
New
8.7M
-
$6.2B0.1%$698.71
53

Other major holders of REGN: BNP PARIBAS FINANCIAL MARKETS, VANGUARD GROUP INC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used